Blockchain technology will be used to track the movement of medicines

Mitsubishi Logistics, a logistics company owned by Mitsubishi Corporation, has launched its own blockchain platform ML Chain. According to Mitsubishi Logistics representatives, ML Chain will allow tracking the movement of medicines — what kind, when and where they arrive.

The new platform is necessary for the company, as Mitsubishi Logistics launched its drug delivery service back in 2015. Blockchain technologies will help make deliveries faster and simplify their logistics. Also, according to ML Chain representatives, the platform will expand the capabilities of the existing service and attract new customers.

Blockchain will also help to efficiently manage product inventory and check its relevance, the developers assured. The ML Chain system is already used by the Japanese company Takeda Pharmaceutical.

While blockchain technologies help in the transportation of medicines, artificial intelligence has learned to detect diseases by analyzing X-rays. As it became known in September, the CheXzero algorithm studied thousands of chest X-rays and their clinical reports to learn how to diagnose diseases on its own. Currently, the artificial intelligence has 377,000 X-rays and 227,000 clinical reports in its memory. CheXzero can independently associate certain types of images with their descriptions and, accordingly, make diagnoses. «For the first time, artificial intelligence has learned from unstructured texts and has been able to link images to diagnoses, working as efficiently as real doctors,» said Ekin Tiu, one of the experts at Harvard Medical School.